
Ambesten Pharmaceuticals Private Limited
About Ambesten Pharmaceuticals Private Limited
Data last updated:
Ambesten Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 23 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33111TG2015PTC099435. Its GSTIN is 36AANCA6086E1ZG (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prasada Rao Gollapudi and Subhashini Muddana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 11 & 12 Flat No. 202 Pragati Nagar, Hyderabad, Telangana, India – 500090.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ambesten Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 11 & 12 Flat No. 202 Pragati Nagar, Hyderabad, Telangana, India – 500090
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Ambesten Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ambesten Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ambesten Pharmaceuticals Private Limited, buy the company report.
Financials of Ambesten Pharmaceuticals Private Limited
FY 2025 filings availableAmbesten Pharmaceuticals Private Limited reported revenue of ₹7,196 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ambesten Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ambesten Pharmaceuticals Private Limited
Ambesten Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasada Rao Gollapudi Also directs: Extrovis Private Limited, Puritan Labs Private Limited | Director | 23 Jun 2015 | 11 Years 4 Months | Current |
| Subhashini Muddana Also directs: Puritan Labs Private Limited | Director | 03 Dec 2015 | 10 Years 11 Months | Current |
Auditor
Ambesten Pharmaceuticals Private Limited is audited by J D P & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D P & Co | FY 2023 | 019550S |
Shareholding
The shareholding of Ambesten Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ambesten Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambesten Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambesten Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ambesten Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AANCA6086E1ZG | Telangana | Active | 01 Jul 2017 |
| 36AANFK5258P1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ambesten Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ambesten Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Bojja Krishnaveni Venkata ceased to be Director on 02 Jan 2016.
Frequently asked questions
Ambesten Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 23 June 2015 (11+ years old) and is registered under CIN U33111TG2015PTC099435.
Ambesten Pharmaceuticals has 2 current directors:
- Prasada Rao Gollapudi - Director
- Subhashini Muddana - Director
The latest financial statements of Ambesten Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ambesten Pharmaceuticals is 36AANCA6086E1ZG, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AANFK5258P1ZH (Telangana).
The CIN (Corporate Identification Number) of Ambesten Pharmaceuticals is U33111TG2015PTC099435. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambesten Pharmaceuticals was incorporated on 23 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bojja Krishnaveni Venkata ceased to be Director on 02 Jan 2016. Subhashini Muddana was appointed as Director on 03 Dec 2015. Bojja Krishnaveni Venkata was appointed as Director on 23 Jun 2015. Ambesten Pharmaceuticals has 4 board changes on record in total.
The registered office of Ambesten Pharmaceuticals is at Plot No. 11 & 12 Flat No. 202 Pragati Nagar, Hyderabad, Telangana, India – 500090.
Ambesten Pharmaceuticals operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Ambesten Pharmaceuticals is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.

